tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
LYEL Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsLYEL Earnings Report this Week: Is It a Buy, Ahead of Earnings?
22d ago
Lyell Immunopharma Appoints New Financial Leadership Team
Premium
Company Announcements
Lyell Immunopharma Appoints New Financial Leadership Team
28d ago
Lyell Immunopharma’s LYL314 Study: A Promising Step in Lymphoma Treatment
Premium
Company Announcements
Lyell Immunopharma’s LYL314 Study: A Promising Step in Lymphoma Treatment
1M ago
Lyell Immunopharma Advances CAR T-Cell Therapies
PremiumCompany AnnouncementsLyell Immunopharma Advances CAR T-Cell Therapies
4M ago
Lyell Immunopharma trading resumes
Premium
The Fly
Lyell Immunopharma trading resumes
4M ago
Lyell Immunopharma trading halted, volatility trading pause
Premium
The Fly
Lyell Immunopharma trading halted, volatility trading pause
4M ago
Lyell Immunopharma target adjusted to $10 from $1 at H.C. Wainwright
PremiumThe FlyLyell Immunopharma target adjusted to $10 from $1 at H.C. Wainwright
5M ago
Lyell Immunopharma Announces Promising CAR T-Cell Trial Data
Premium
Company Announcements
Lyell Immunopharma Announces Promising CAR T-Cell Trial Data
6M ago
Lyell Immunopharma’s LYL314 shows strong response in Phase 1/2 lymphoma trial
Premium
The Fly
Lyell Immunopharma’s LYL314 shows strong response in Phase 1/2 lymphoma trial
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100